Completed Clinical Trials

Active Symptom Control With or Without Chemotherapy in Treating Patients With Malignant Pleural Mesothelioma

By April 24, 2017 No Comments

Condition

Malignant Mesothelioma

Estimated Enrollment: 840

Age Group: 18 Years and older   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Allocation: Randomized|Primary Purpose: Treatment

Study ID Numbers: BTS-MRC-MS01|CDR0000347461|ISRCTN54469112|EU-20349

Study First Received: January 9, 2004

Last Updated: August 6, 2013

Estimated Primary Completion Date: null

 

Primary Outcome Measures:

Overall survival|Palliation of chest pain, breathlessness, malaise (e.g., feeling weak, tiredness, anorexia), and sweating attacks|Performance status as measured by WHO grade|Analgesic usage|Toxicity as measured by the NCIC CTC|Quality of life as assessed by the European Organization for Research and Treatment of Cancer|Tumor response as measured by the RECIST criteria|Progression-free survival as measured by CT scan

Sponsors and Collaborators:

Medical Research Council|National Cancer Institute (NCI)

Website Link: https://ClinicalTrials.gov/show/NCT00075699

Leave a Reply

Call Now